EU Aduhelm Filing: Biogen Faces Second High-Stakes Meeting At EMA

 
• By Neena Brizmohun
Aduhelm is Biogen and Eisai's drug for Alzheimer’s disease • Source: Alamy

More from Europe

More from Geography